Evidence map›Paper›PMID 41717271›Full record

ArticleJournal of biotechnology and biomedicine2026

An Investigation to Identify the Anti-Cancer Properties of Novel Rhenium Compounds in Prostate and Lung Cancer Cell Lines.

Christopher Krauss, Jazmine Cuffee, Narendra Banerjee, Erik Armstrong, Satyendra Banerjee, Somiranjan Ghosh, Tanmoy Mondal, Zahidur Abedin, Santosh Mandal, Hirendra Nath Banerjee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of biotechnology and biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christopher KraussDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.
Jazmine CuffeeDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.
Narendra BanerjeeDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.
Erik ArmstrongDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.
Satyendra BanerjeeDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.
Somiranjan GhoshDepartment of Biology, Howard University, Washington DC, USA.
Tanmoy MondalDepartments of Pediatrics and Child Health, College of Medicine, Howard University, Washington DC, USA.
Zahidur AbedinPrimBio Research Institute, Garnet Valley, Pennsylvania, USA.
Santosh MandalDepartment of Chemistry, Morgan State University, Baltimore, MD, USA.
Hirendra Nath BanerjeeDepartment of Natural Sciences, Pharmaceutical Science, Computer Science, Engineering & Technology, Elizabeth City State University Campus of the University of North Carolina, Elizabeth City, 27909, USA.

Funding

Elizabeth City State University Minority Access to Research Careers (E-MARC) UndeT34GM100831 · NIGMS · ELIZABETH CITY STATE UNIVERSITY · PI BANERJEE, HIRENDRA N · 2012 to 2022
$1.9M
NIGMS NIH HHS T34 GM100831
6 · The paper itself

Abstract

The anti-cancer properties of rhenium compounds have attracted researchers for decades. In this study, rhenium-based PR series compounds (PR1-PR10) were exposed to LNCaP and E006AA prostate cancer cell lines to verify their toxicities. Among the compounds, PR7 was tested further to determine its effects on the lung cancer cell lines A549 using RNA sequencing and Ingenuity Pathway Analysis (IPA) software. In this study, IPA analysis was explored further to determine that PR7 played a role in various canonical pathways. The pathways affected are:

Indexed as

ApoptosisIPARhenium CompoundsTubulin

Identifiers

PMID41717271
PMCPMC12916130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.